ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,381.35
0.33%
Dow Jones
39,387.76
0.85%
Gold vs US Dollar
2,347.09
1.69%
Brent Oil
83.95
0.47%
Bitcoin
63,005.86
2.97%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Fortress Biotech Inc (FBIO)

  7. Fortress Biotech Inc (FBIO) News

Fortress Biotech (FBIO)

Fortress Biotech Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:FBIO
DateTimeSourceHeadlineSymbolCompany
07/05/202413:30GlobeNewswire Inc.Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024NASDAQ:FBIOFortress Biotech Inc
02/05/202421:01GlobeNewswire Inc.Mustang Bio Announces Closing of $4 Million Public OfferingNASDAQ:FBIOFortress Biotech Inc
01/05/202421:01GlobeNewswire Inc.Journey Medical Corporation Appoints Joseph Benesch as Chief Financial OfficerNASDAQ:FBIOFortress Biotech Inc
30/04/202401:00GlobeNewswire Inc.Mustang Bio Announces Pricing of $4 Million Public OfferingNASDAQ:FBIOFortress Biotech Inc
29/04/202413:00GlobeNewswire Inc.Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross ProceedsNASDAQ:FBIOFortress Biotech Inc
25/04/202413:30GlobeNewswire Inc.Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024NASDAQ:FBIOFortress Biotech Inc
24/04/202412:30GlobeNewswire Inc.Avenue Therapeutics Announces Reverse Stock SplitNASDAQ:FBIOFortress Biotech Inc
28/03/202420:05GlobeNewswire Inc.Fortress Biotech Reports 2023 Financial Results and Recent Corporate HighlightsNASDAQ:FBIOFortress Biotech Inc
28/03/202413:00GlobeNewswire Inc.Mustang Bio Announces Vision for CAR T-Cell Therapy Platform Expansion into Autoimmune DiseasesNASDAQ:FBIOFortress Biotech Inc
25/03/202412:30GlobeNewswire Inc.Avenue Therapeutics to Host Virtual Key Opinion Leader (KOL) Event on April 4, 2024NASDAQ:FBIOFortress Biotech Inc
21/03/202420:01GlobeNewswire Inc.Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate HighlightsNASDAQ:FBIOFortress Biotech Inc
18/03/202420:05GlobeNewswire Inc.Avenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate HighlightsNASDAQ:FBIOFortress Biotech Inc
18/03/202412:30GlobeNewswire Inc.Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of RosaceaNASDAQ:FBIOFortress Biotech Inc
15/03/202412:30GlobeNewswire Inc.Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024NASDAQ:FBIOFortress Biotech Inc
15/03/202412:15GlobeNewswire Inc.Avenue Therapeutics Receives Positive Listing Determination from NasdaqNASDAQ:FBIOFortress Biotech Inc
13/03/202412:30GlobeNewswire Inc.Journey Medical Corporation to Participate in the 36th Annual ROTH ConferenceNASDAQ:FBIOFortress Biotech Inc
12/03/202412:30GlobeNewswire Inc.Fortress Biotech to Participate in 36th Annual ROTH ConferenceNASDAQ:FBIOFortress Biotech Inc
11/03/202412:30GlobeNewswire Inc.Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adults at 2024 AAD Annual MeetingNASDAQ:FBIOFortress Biotech Inc
11/03/202412:00GlobeNewswire Inc.Avenue Therapeutics to Present BAER-101 Preclinical Data at American Society for Experimental Neurotherapeutics (ASENT) 2024 Annual MeetingNASDAQ:FBIOFortress Biotech Inc
07/03/202412:30GlobeNewswire Inc.Mustang Bio Announces Publication in Nature Medicine of Data from Phase 1 Trial Evaluating MB-101 IL13Rα2-targeted CAR T-Cells in High-Grade GliomaNASDAQ:FBIOFortress Biotech Inc
04/03/202413:30GlobeNewswire Inc.Fortress Biotech and Cyprium Therapeutics Announce $4.1 Million Grant from NINDS to Further Development of AAV-ATP7A Gene Therapy for Menkes DiseaseNASDAQ:FBIOFortress Biotech Inc
22/02/202413:30GlobeNewswire Inc.Avenue Therapeutics Announces Publication in Drug Development Research Highlighting First-In-Class Preclinical Data of BAER-101 in a Translational Model of Absence EpilepsyNASDAQ:FBIOFortress Biotech Inc
11/01/202413:30GlobeNewswire Inc.Mustang Bio to Participate in the B. Riley Securities 4th Annual Oncology ConferenceNASDAQ:FBIOFortress Biotech Inc
11/01/202413:00GlobeNewswire Inc.Avenue Therapeutics to Present at Sidoti January Micro-Cap Investor ConferenceNASDAQ:FBIOFortress Biotech Inc
05/01/202414:15GlobeNewswire Inc.Avenue Therapeutics Enters into Warrant Exercise Transactions for $5.0 Million in ProceedsNASDAQ:FBIOFortress Biotech Inc
05/01/202413:30GlobeNewswire Inc.Journey Medical Corporation Submits New Drug Application to FDA for DFD-29 to Treat RosaceaNASDAQ:FBIOFortress Biotech Inc
04/01/202413:30GlobeNewswire Inc.Avenue Therapeutics Reaches Final Agreement with the U.S. FDA for the Phase 3 Safety Study for IV TramadolNASDAQ:FBIOFortress Biotech Inc
03/01/202421:01GlobeNewswire Inc.Fortress Biotech Announces Closing of $11 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNASDAQ:FBIOFortress Biotech Inc
02/01/202421:05GlobeNewswire Inc.Journey Medical Corporation Secures Credit Facility with SWK Holdings for up to $20 MillionNASDAQ:FBIOFortress Biotech Inc
02/01/202413:30GlobeNewswire Inc.Avenue Therapeutics Announces Completion of Enrollment in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease)NASDAQ:FBIOFortress Biotech Inc
 Showing the most relevant articles for your search:NASDAQ:FBIO

Your Recent History

LSE
TERN
Tern
LSE
POS
Plexus
LSE
SCE
Surface Transforms
LSE
KEFI
Kefi Gold And Copper
LSE
BIRD
Blackbird
LSE
GOLD
LSE
SYME
Supply@me Capital
LSE
AGL
Angle
LSE
ITV
Itv
LSE
GCM
Gcm Resources
LSE
PET
Petrel Resources
LSE
BOO
Boohoo
LSE
GDR
Genedrive
LSE
SAR
Sareum
LSE
GWMO
Great Western Mining
LSE
LLOY
Lloyds Banking
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved